- Home
- PEBK vs SXTC Comparison
PEBK vs SXTC Comparison
Compare PEBK & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEBK | SXTC |
|---|---|---|
| Founded | 1912 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.0M | 177.7M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | PEBK | SXTC |
|---|---|---|
| Price | $36.89 | $0.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.7K | ★ 21.4M |
| Earning Date | 02-11-2026 | 08-19-2019 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | ★ 3.81 | N/A |
| EPS | ★ 3.06 | N/A |
| Revenue | ★ $85,500,000.00 | $1,537,987.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.06 | ★ N/A |
| Revenue Growth | ★ 6.88 | N/A |
| 52 Week Low | $23.74 | $0.09 |
| 52 Week High | $38.46 | $7.84 |
Technical Indicators
Market Signals| Indicator | PEBK | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 59.51 | 23.90 |
| Support Level | $36.05 | $0.09 |
| Resistance Level | $37.60 | $6.98 |
| Average True Range (ATR) | 0.79 | 0.58 |
| MACD | -0.10 | -0.11 |
| Stochastic Oscillator | 72.11 | 0.08 |
Price Performance
Historical ComparisonAbout PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.